LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

Search

Accuray Inc

Fermé

SecteurSoins de santé

0.39 -4.88

Résumé

Variation du prix de l'action

24h

Actuel

Min

0.38

Max

0.42

Chiffres clés

By Trading Economics

Revenu

7.9M

-14M

Ventes

8.3M

102M

BPA

-0.108

Marge bénéficiaire

-13.468

Employés

990

EBITDA

7M

-3.3M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+376.19% upside

Dividendes

By Dow Jones

Prochains Résultats

29 avr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-33M

58M

Ouverture précédente

5.27

Clôture précédente

0.39

Sentiment de l'Actualité

By Acuity

50%

50%

156 / 351 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Accuray Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

17 mars 2026, 22:42 UTC

Résultats

Prudential PLC 2025 Adjusted Operating Profit Rises

17 mars 2026, 21:40 UTC

Résultats

Alimentation Couche-Tard Records Higher Profit, Revenue in 3Q

17 mars 2026, 23:56 UTC

Market Talk

BHP's Next CEO Likely to Build On Existing Strategic Direction -- Market Talk

17 mars 2026, 23:46 UTC

Market Talk

Nikkei May Rise After Recent Selloffs -- Market Talk

17 mars 2026, 23:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 mars 2026, 23:42 UTC

Market Talk

RBA's Return to Policy Tightening Will Work -- Market Talk

17 mars 2026, 23:38 UTC

Market Talk

Gold Edges Lower on Possible Position Adjustments Before FOMC Decision -- Market Talk

17 mars 2026, 23:24 UTC

Market Talk

Global Energy Roundup: Market Talk

17 mars 2026, 23:24 UTC

Market Talk

New Woodside CEO Seen as Low-Risk Appointment -- Market Talk

17 mars 2026, 22:22 UTC

Market Talk

BHP Hands Reins to Growth-Focused Executive -- Market Talk

17 mars 2026, 22:20 UTC

Résultats

Prudential PLC 2025 New Business Profit $2.78B Vs. $2.46B >2378.HK

17 mars 2026, 22:20 UTC

Résultats

Prudential PLC 2025 Adj Operating Profit $3.31B Vs. $3.13B >2378.HK

17 mars 2026, 22:07 UTC

Résultats

Nvidia Says It Is Restarting Production of AI Chips for Sale in China -- WSJ

17 mars 2026, 22:05 UTC

Résultats

ZTO Express (Cayman): Frank Zhen Wei to Resign From Board

17 mars 2026, 22:04 UTC

Résultats

ZTO Express (Cayman): Board Approves Repurchase of Up to $1.5B of Shares Over Next 24 Months >ZTO

17 mars 2026, 22:03 UTC

Résultats

ZTO Express (Cayman) Raises Semiannual Dividend to 39c Vs. 30c >ZTO

17 mars 2026, 22:01 UTC

Résultats

ZTO Express (Cayman) 4Q Adj EPS 47c >ZTO

17 mars 2026, 22:01 UTC

Résultats

ZTO Express (Cayman) 4Q Rev $2.08B >ZTO

17 mars 2026, 22:01 UTC

Résultats

ZTO Express (Cayman) 4Q EPS 47c >ZTO

17 mars 2026, 21:26 UTC

Résultats

Oklo Stock Wavers After Earnings, but the Nuclear Start-Up Has Good News -- Barrons.com

17 mars 2026, 21:09 UTC

Résultats

Couche-Tard: 12 Company-Operated Stores Acquired During 3Q

17 mars 2026, 21:08 UTC

Résultats

Couche-Tard 3Q Consolidated Same-Store Merchandise Revenue Up 2% >ATD.T

17 mars 2026, 21:08 UTC

Résultats

Couche-Tard 3Q Adj EPS 81c >ATD.T

17 mars 2026, 21:07 UTC

Résultats

Couche-Tard 3Q EPS 82c >ATD.T

17 mars 2026, 21:06 UTC

Résultats

Couche-Tard 3Q Rev $21.8B >ATD.T

17 mars 2026, 21:05 UTC

Résultats

Couche-Tard 3Q Adj EPS 81c >ATD.T

17 mars 2026, 21:05 UTC

Résultats

Couche-Tard 3Q Rev $21.8B >ATD.T

17 mars 2026, 21:05 UTC

Résultats

Couche-Tard 3Q EPS 82c >ATD.T

17 mars 2026, 21:05 UTC

Résultats

Couche-Tard 3Q Net $757.2M >ATD.T

17 mars 2026, 20:50 UTC

Market Talk
Principaux Événements d'Actualité

Energy & Utilities Roundup: Market Talk

Comparaison

Variation de prix

Accuray Inc prévision

Objectif de Prix

By TipRanks

376.19% hausse

Prévisions sur 12 Mois

Moyen 2 USD  376.19%

Haut 2 USD

Bas 2 USD

Basé sur 1 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

1 ratings

1

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

1.28 / 1.61Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

156 / 351Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Accuray Inc

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
help-icon Live chat